The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review

Shaw, 1994, Assessment of medical treatments for menorrhagia, Br J Obstet Gynaecol, 101, 15, 10.1111/j.1471-0528.1994.tb13690.x Coulter A, Kelland J, Long A, et al. The Management of Menorrhagia. Effective Health Care Bulletin No. 9; August, 1995. Reid, 1994, The medical management of menorrhagia in general practice, The Diplomate, 1, 92 1983, 21 Bradlow, 1992, Patterns of Referral, Oxford Health Services Research Unit, 20 Andersson, 1990, Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia, Br J Obstet Gynaecol, 97, 690, 10.1111/j.1471-0528.1990.tb16240.x Apgar, 1997, Dysmenorrhoea and dysfunctional uterine bleeding, Primary Care: Clinics and Office Practice, 24, 161, 10.1016/S0095-4543(22)00093-8 Morbidity Statistics in General Practice. Fourth National Survey. 1991–1992. London: HMSO. Hallberg, 1966, Menstrual blood loss: a population study, Acta Obstet Gynecol Scand, 45, 320, 10.3109/00016346609158455 Cameron, 1989, Dysfunctional uterine bleeding, Balliere's Clin Obstet Gynecol, 3, 315, 10.1016/S0950-3552(89)80024-0 Chimbira, 1980, Relation between measured menstrual blood loss and patient's subjective measurement of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area, Br J Obstet Gynaecol, 87, 603, 10.1111/j.1471-0528.1980.tb05013.x Higham, 1990, Assessment of menstrual blood loss using a pictorial chart, Br J Obstet Gynaecol, 97, 734, 10.1111/j.1471-0528.1990.tb16249.x Duncan, 1997, Paediatric and adolescent gynaecology: menstrual problems [minisymposium], The Diplomate, 4, 200 Duckitt, 1998, Is medical management of menorrhagia obsolete?, Br J Obstet Gynaecol, 105, 569, 10.1111/j.1471-0528.1998.tb10168.x Reid, 2000, Assessment of menstrual blood loss using a pictorial chart: a validation study, Br J Obstet Gynaecol, 107, 320, 10.1111/j.1471-0528.2000.tb13225.x RCOG Evidence-based Guidelines No.1. The Initial Management of Menorrhagia. The Royal College of Obstetricians and Gynaecologists, London, 1998. Duckitt, 1999, Guidelines promote effective general practitioner treatment of menorrhagia, Guidelines in Practice, 2, 19 Fender, 1999, Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study, BMJ, 318, 1246, 10.1136/bmj.318.7193.1246 Preston, 1995, Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia, Br J Obstet Gynaecol, 102, 401, 10.1111/j.1471-0528.1995.tb11293.x Coulter, 1995, Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice, Int J Technol Assess Health Care, 11, 456, 10.1017/S0266462300008679 Ylikorkala, 1983, Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices, Br J Obstet Gynaecol, 90, 78, 10.1111/j.1471-0528.1983.tb06751.x Cameron, 1987, The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia, Prostaglandins, 34, 99, 10.1016/0090-6980(87)90267-X Irvine, 1998, Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia, Br J Obstet Gynaecol, 105, 592, 10.1111/j.1471-0528.1998.tb10172.x Scott, 1999, Cost effective prescribing for menorrhagia, Prescriber, 10, 95 Higham, 1991, Risk–benefit assessment of drugs used for the treatment of menstrual disorders, Drug Safety, 6, 183, 10.2165/00002018-199106030-00004 Guidelines for the Management of Heavy Menstrual Bleeding. National Advisory Committee on health and disability, New Zealand, 1998. National Health Service Executive. National Schedule of Reference Costs, May 1999: Appendix 1 A. Coulter, 1991, Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice, Br J Obstet Gynaecol, 98, 789, 10.1111/j.1471-0528.1991.tb13484.x Hollingworth, 1994, The levonorgestrel intrauterine device, The Diplomate, 1, 247 Barrington, 1997, The levonorgestrel intrauterine system in the management of menorrhagia, Br J Obstet Gynaecol, 104, 614, 10.1111/j.1471-0528.1997.tb11542.x Gath, 1982, Hysterectomy and psychiatric disorder, Br J Psychiat, 140, 335, 10.1192/bjp.140.4.335 Coulter, 1994, Quality of life and patient satisfaction following treatment for menorrhagia, Fam Pract, 11, 394, 10.1093/fampra/11.4.394 Pinion, 1994, Randomised trial of hysterectomy, endometrial laser ablation and transcervical endometrial resection for dysfunctional uterine bleeding, BMJ, 309, 979, 10.1136/bmj.309.6960.979 Clarke, 1995, Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study, Br J Obstet Gynaecol, 102, 611, 10.1111/j.1471-0528.1995.tb11398.x Dwyer, 1993, Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia, Br J Obstet Gynaecol, 100, 237, 10.1111/j.1471-0528.1993.tb15237.x Crosignani, 1997, Endometrial resection versus vaginal hysterectomy for menorrhagia; long term clinical and quality of life outcomes, Am J Obstet Gynecol, 177, 95, 10.1016/S0002-9378(97)70445-9 McAuliffe, 1996, Patient satisfaction following transcervical resection of the endometrium, Irish J Med Sci, 165, 170, 10.1007/BF02940244 Sculpher, 1993, An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia, Br J Obstet Gynaecol, 100, 244, 10.1111/j.1471-0528.1993.tb15238.x Lilford, 1997, Hysterectomy: will it pay the bills in 2007? [editorial], BMJ, 314, 160, 10.1136/bmj.314.7075.160 Grimes, 1982, Diagnostic dilation and curettage: a reappraisal, Am J Obstet Gynecol, 142, 1, 10.1016/S0002-9378(16)32276-1 Lewis, 1993, Diagnostic dilatation and curettage in young women, BMJ, 306, 225, 10.1136/bmj.306.6872.225 Haynes, 1977, Measurement of menstrual blood loss in patients complaining of menorrhagia, Br J Obstet Gynaecol, 84, 763, 10.1111/j.1471-0528.1977.tb12490.x Hampton N. Mirena: novel hormonal intrauterine contraception. Prescriber, 5 November, 1995. Harrison-Woolrych, 1998, Levonorgestrel intrauterine device can be left in place for five years [letter], BMJ, 317, 149, 10.1136/bmj.317.7151.149a Bromham, 1991, New developments with IUDs: devices, patients and their management, Br J Fam Plann, 15, 34 Luukkainen, 1993, The levonorgestrel-releasing IUD, Br J Fam Plann, 19, 221 Bromham DR. Gynaecological aspects [extended abstract]. Mirena Launch Symposium Contraception for the 21st Century, 16th May 1995, London; 4: 7–10. Davie, 1996, Developments in contraception: new hormone delivery systems [minisymposium], The Diplomate, 3, 184 Luukkainen, 1986, Five years’ experience with levonorgestrel-releasing IUDs, Contraception, 33, 139, 10.1016/0010-7824(86)90080-6 Nilsson, 1981, Intrauterine contraception with levonorgestrel: a comparative randomised clinical performance study, Lancet, 1, 577, 10.1016/S0140-6736(81)92031-6 Tang, 1995, Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability, Contraception, 51, 231, 10.1016/0010-7824(95)00038-C Guillebaud, 1997, Use of licensed products in an unlicensed way. Contraception Today, 94 Sivin, 1991, Prolonged intrauterine contraception: a seven year randomized study of the levonorgestrel 20 μg/day (LNg 20) and the copper T 380 Ag IUDs, Contraception, 44, 473, 10.1016/0010-7824(91)90149-A Faúndes, 1993, A Latin American experience with levonorgestrel IUD, Ann Med, 25, 149, 10.3109/07853899309164159 Sivin, 1994, Health during prolonged use of levonorgestrel 20 μg/d and the copper TCu 380 Ag intrauterine contraceptive devices, Fertil Steril, 61, 70, 10.1016/S0015-0282(16)56455-3 Nilsson, 1983, Two years’ experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study, Fertil Steril, 39, 187, 10.1016/S0015-0282(16)46817-2 Bromham, 1996, Choosing and fitting an intrauterine contraceptive, The Diplomate, 3, 292 Xiao, 1995, Effect of levonorgestrel-releasing intrauterine device on hormone profile and menstrual pattern after long term use, Contraception, 51, 359, 10.1016/0010-7824(95)00102-G Li, 1992, Progestogen only contraceptives and ectopic pregnancy, Br J Fam Plann, 18, 79 Chi, 1993, The TCu 380 A (Ag), MLCu375 and Nova TIUDs and the IUD daily releasing 20 μg levonorgestrel–four pillars of IUD contraception for the nineties and beyond?, Contraception, 47, 325, 10.1016/0010-7824(93)90031-2 Chi, 1994, The non-contraceptive effects of the levonorgestrel-releasing intrauterine device, Adv Contraception, 10, 271, 10.1007/BF01984125 Andersson, 1994, Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial, Contraception, 49, 56, 10.1016/0010-7824(94)90109-0 Panay, 1998, Problems with HRT: progestogen side effects [minisymposium], The Diplomate, 5, 37 Robinson, 1989, Functional ovarian cysts associated with the levonorgestrel releasing intrauterine device, Br J Fam Plann, 14, 131 Sturridge, 1996, A risk-benefit assessment of the levonorgestrel-releasing intrauterine system, Drug Safety, 15, 430, 10.2165/00002018-199615060-00006 Luukkainen, 1995, as a method of contraception with therapeutic properties, Contraception, 52, 269, 10.1016/0010-7824(95)00210-2 British National Formulary, 1998: 7. Long-acting progestogen-only contraception. Drug Therap Bull 1996; 34: 93–96. National Health Service General Medical Services. Statement of Fees and Allowances Payable to General Medical Practitioners in England and Wales. Department of Health, Welsh Office. London: HMSO, 1999. National Health Service Executive. General Practitioner Fundholding Price List 1998/99. London: HMSO, 1998. Cooke, 1998, Progesterone/progestagen releasing IUCDs vs either placebo or any other medication for heavy menstrual bleeding Hirsch NA. Levonorgestrel IUD for Menorrhagia. Canberra: Australian Institute of Health and Welfare, 1993. Luukkainen, 1987, Effective contraception with the levonorgestrel-releasing intrauterine device 12-month report of a European multicentre study, Contraception, 36, 169, 10.1016/0010-7824(87)90012-6 Sivin, 1990, Long term contraception with the levonorgestrel 20μg/day (LNG 20) and the copper T 380 Ag intrauterine devices: a five year randomized study, Contraception, 42, 361, 10.1016/0010-7824(90)90046-X Toivonen, 1991, Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years’ comparative experience of levonorgestrel-and copper-releasing intrauterine devices, Obstet Gynecol, 77, 261, 10.1097/00006250-199102000-00019 Sivin, 1992, Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel or copper TCu 380 Ag intrauterine contraceptive devices, Am J Obstet Gynecol, 166, 1208, 10.1016/S0002-9378(11)90607-3 Pakarinen, 1995, The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation, Hum Reprod, 10, 2390, 10.1093/oxfordjournals.humrep.a136305 Faúndes, 1988, The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anaemia during fertility regulation, Int J Gynecol Obstet, 26, 429, 10.1016/0020-7292(88)90341-4 Bounds, 1993, Clinical experience with a levonorgestrel-releasing intrauterine contraceptive device (LNG-IUD) as a contraceptive and in the treatment of menorrhagia, Br J Fam Plann, 19, 193 Nilsson, 1977, Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing IUD, Nova-T Copper device, Contraception, 15, 379, 10.1016/0010-7824(77)90001-4 Nilsson, 1982, Clinical performance of a new levonorgestrel-releasing IUD: a randomised comparison with a Nova-T copper device, Contraception, 25, 345, 10.1016/0010-7824(82)90092-0 Sivin, 1984, Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380 Ag and levonorgestrel 20μg/day devices, Contraception, 30, 443, 10.1016/0010-7824(84)90036-2 Sivin, 1987, Two years of intrauterine contraception with levonorgestrel and with copper; a randomized comparison of the TCu 380 Ag and levonorgestrel 20 μg/day devices, Contraception, 35, 245, 10.1016/0010-7824(87)90026-6 Indian Council of Medical Research Task Force on IUDs. Randomised clinical trials with intrauterine devices: a 36-month study. Contraception 1989; 39: 37–52. Scholten, 1989, Menstrual blood loss with the levonorgestrel intrauterine device Nova T, Multiload CU 250 intrauterine devices [thesis], 35 Gao, 1990, Comparison of the clinical performance, contraceptive efficacy and acceptability of the levonorgestrel releasing IUD, Norplant-2 implants in China, Contraception, 41, 485, 10.1016/0010-7824(90)90058-4 Xiao, 1990, Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device, Contraception, 41, 353, 10.1016/0010-7824(90)90035-T Wang, 1992, Three years’ experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: a randomized comparative study, Adv Contraception, 8, 105, 10.1007/BF01849748 Suvisaari, 1996, Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system, Contraception, 54, 201, 10.1016/S0010-7824(96)00189-8 Milsom, 1991, A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia, Am J Obstet Gynecol, 164, 879, 10.1016/S0002-9378(11)90533-X Fedele, 1997, Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device, Fertil Steril, 68, 426, 10.1016/S0015-0282(97)00245-8 Scholten, 1989, Treatment of menorrhagia by intrauterine administration of levonorgestrel, 47 Lähteenmäki, 1998, Open randomised study of use of levonorgestrel intrauterine system as alternative to hysterectomy, BMJ, 316, 1122, 10.1136/bmj.316.7138.1122 Crosignani, 1997, Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding, Obstet Gynecol, 90, 257, 10.1016/S0029-7844(97)00226-3 Kittelsen, 1998, A randomised study comparing levonorgestrel intrauterine system (LNG-IUS) and transcervical resection of the endometrium (TCRE) in the treatment of menorrhagia: preliminary results, Gynecol Endos, 7, 61, 10.1046/j.1365-2508.1998.00165.x Sculpher, 1996, Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery, Br J Obstet Gynaecol, 103, 142, 10.1111/j.1471-0528.1996.tb09666.x